Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Patent Number 11975001
US 11975001 B2Filled DateMay 4, 2023
Priority DateOct 7, 2008
Publication DateNov 2, 2023
Expiration DateOct 6, 2028
Inventor/ApplicantsBernd Harald Liepold
Kieran James Lennon
Michael Karl Bechtold
Julie Kay Cahill
Claudia Bettina Packhaeuser
Benedikt Steitz
Katja Maren Fastnacht
Kieran James Lennon
Michael Karl Bechtold
Julie Kay Cahill
Claudia Bettina Packhaeuser
Benedikt Steitz
Katja Maren Fastnacht
ExaminesANTHOPOLOS, PETER
Art Unit1611
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.